Female Health Co. Gets European Patent on Improved Condom for Women
November 17, 2009
In a statement issued Nov. 12, Chicago-based Female Health Co. reported it has received a European patent on FC2, its second-generation female condom. The improved product was approved Oct. 1 by the U.S. Food and Drug Administration. The company said its patent applications are pending in the United States and Japan, while patents have already been issued in Canada, Australia, China, and South Africa.
Chicago Daily Herald
11.16.2009; Bloomberg News
Second-Generation FC2 Female Condom, Cheaper and Quieter Than Its Mama, Gives Women New Option to Take Control of Their HIV Prevention
This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.